SRS medical names new CEO.Lee Brody, a 15-year veteran of Billerica, Mass.-based SRS SRS, SRS-A
see slow-reacting substance. Medical Corp., has been appointed the company's new CEO. Most recently chief operating officer Chief Operating Officer (COO)
The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. , Brody will take charge of corporate strategy and work closely with senior management on expanding partnerships and driving new product acquisition.
Brody received his bachelor's and master's degrees in biomedical engineering from Boston University, and his master's degree in business administration from Northeastern University in Boston, Mass.
His plans for the company include focusing more energy on its new product, the CT3000 non-invasive pressure-flow system. The urology device measures bladder pressure in male patients to provide a definitive diagnosis for either bladder outlet obstruction bladder outlet obstruction Urology A general condition for any difficulty in the passage of urine from the bladder to the urethra which is more common in ♂, and due to BPH. See Benign prostate hypertrophy. related to an enlarged prostate, or low bladder contractility. The CT3000 UroCuff will be the first non-invasive test for male urinary flow pressure, according to the company.
"We are pleased with the clinical success of the CT3000 and believe its widespread use results in better diagnosis and outcomes," Brody said. "The CT3000 complements our company's long history of excellence and innovation in urology, across urodynamics urodynamics /uro·dy·nam·ics/ (-di-nam´iks) the dynamics of the propulsion and flow of urine in the urinary tract.urodynam´ic
the dynamics of the propulsion and flow of urine in the urinary tract. , ultrasound and related product lines."
The company also announced that SRS Medical and its worldwide development partner, MediPlus Ltd., have expanded their partnership on the CT3000 and other clinical products. In addition, SRS Medical and its investment partners, Schooner Capital LLC and 20/20 HealthCare Partners LLC, have completed an additional financing round.